Fibrotic Remodeling during Persistent Atrial Fibrillation: In Silico Investigation of the Role of Calcium for Human Atrial Myofibroblast Electrophysiology.
Jorge SánchezBeatriz TrenorJavier SaizOlaf DösselAxel LoewePublished in: Cells (2021)
During atrial fibrillation, cardiac tissue undergoes different remodeling processes at different scales from the molecular level to the tissue level. One central player that contributes to both electrical and structural remodeling is the myofibroblast. Based on recent experimental evidence on myofibroblasts' ability to contract, we extended a biophysical myofibroblast model with Ca2+ handling components and studied the effect on cellular and tissue electrophysiology. Using genetic algorithms, we fitted the myofibroblast model parameters to the existing in vitro data. In silico experiments showed that Ca2+ currents can explain the experimentally observed variability regarding the myofibroblast resting membrane potential. The presence of an L-type Ca2+ current can trigger automaticity in the myofibroblast with a cycle length of 799.9 ms. Myocyte action potentials were prolonged when coupled to myofibroblasts with Ca2+ handling machinery. Different spatial myofibroblast distribution patterns increased the vulnerable window to induce arrhythmia from 12 ms in non-fibrotic tissue to 22 ± 2.5 ms and altered the reentry dynamics. Our findings suggest that Ca2+ handling can considerably affect myofibroblast electrophysiology and alter the electrical propagation in atrial tissue composed of myocytes coupled with myofibroblasts. These findings can inform experimental validation experiments to further elucidate the role of myofibroblast Ca2+ handling in atrial arrhythmogenesis.
Keyphrases
- transforming growth factor
- atrial fibrillation
- pulmonary fibrosis
- catheter ablation
- left atrial
- epithelial mesenchymal transition
- mass spectrometry
- multiple sclerosis
- protein kinase
- ms ms
- endothelial cells
- molecular docking
- left atrial appendage
- oral anticoagulants
- systemic sclerosis
- left ventricular
- idiopathic pulmonary fibrosis
- mitral valve
- percutaneous coronary intervention
- direct oral anticoagulants
- acute coronary syndrome
- big data
- climate change
- electronic health record